Kenyan AIDS Vaccine Initiative Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2015
NCT02514018
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Kenyan AIDS Vaccine Initiative - Institute of Clinical Research (KAVI-ICR)

Active Ingredients

Drugs in Phase 4 Trials (1)

live attenuated varicella vaccine (Varivax) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chickenpox (Phase 4)

Herpes Zoster (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1